日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphoma

对体弱的中枢神经系统淋巴瘤患者进行利妥昔单抗和高剂量甲氨蝶呤的预处理,以重新评估其是否适合接受强化诱导治疗。

Wendler, Julia; Lewis, Richard I; Kutilina, Alexandra; Knott, Markus; Isbell, Lisa Kristina; Valk, Elke; Borchmann, Peter; Heger, Jan-Michel; Illerhaus, Gerald; Schorb, Elisabeth

Role of Geriatric Assessment Scores as Predictors of Intensive Therapy Feasibility and Survival in Elderly Patients with Primary CNS Lymphoma

老年评估评分在预测老年原发性中枢神经系统淋巴瘤患者强化治疗可行性和生存率方面的作用

Isbell, Lisa K; Vreden, Annika; Ihorst, Gabriele; Uibeleisen, Roswitha; Friedl, Alexander; Neumaier, Simone; Wendler, Julia; Orban, Andras; Lauer, Eliza M; Fricker, Heidi; Malenica, Natalie; Illerhaus, Gerald; Schorb, Elisabeth

Optimized BERT-based NLP outperforms zero-shot methods for automated symptom detection in clinical practice

在临床实践中,基于优化的 BERT 自然语言处理方法在自动症状检测方面优于零样本方法。

Diaz Ochoa, Juan G; Layer, Natalie; Mahr, Jonas; Mustafa, Faizan E; Menzel, Christian U; Müller, Martina; Schilling, Tobias; Illerhaus, Gerald; Knott, Markus; Krohn, Alexander

Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

原发性中枢神经系统淋巴瘤:EHA-ESMO临床实践指南(诊断、治疗和随访)

Ferreri, Andreas J M; Illerhaus, Gerald; Doorduijn, Jeanette K; Auer, Dorothee P; Bromberg, Jacoline E C; Calimeri, Teresa; Cwynarski, Kate; Fox, Christopher P; Hoang-Xuan, Khê; Malaise, Denis; Ponzoni, Maurilio; Schorb, Elisabeth; Soussain, Carole; Specht, Lena; Zucca, Emanuele; Buske, Christian; Jerkeman, Mats; Dreyling, Martin

Warehouse-based, immunopeptidome-guided design of personalised peptide vaccines shows feasibility in clinical trial evaluation in CLL patients

基于仓库的、免疫肽组指导的个性化肽疫苗设计在慢性淋巴细胞白血病患者的临床试验评估中显示出可行性。

Heitmann, Jonas S; Jung, Susanne; Wacker, Marcel; Maringer, Yacine; Nelde, Annika; Bauer, Jens; Denk, Monika; Hoenisch-Gravel, Naomi; Richter, Marion; Oezbek, Melek T; Dubbelaar, Marissa L; Bilich, Tatjana; Pumptow, Marina; Martus, Peter; Illerhaus, Gerald; Denzlinger, Claudio; Steinbach, Francesca; Aulitzky, Walter-Erich; Müller, Martin R; Dörfel, Daniela; Rammensee, Hans-Georg; Salih, Helmut R; Walz, Juliane S

Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas

循环肿瘤DNA谱分析在脑淋巴瘤的检测、风险分层和分类中的应用

Mutter, Jurik A; Alig, Stefan K; Esfahani, Mohammad S; Lauer, Eliza M; Mitschke, Jan; Kurtz, David M; Kühn, Julia; Bleul, Sabine; Olsen, Mari; Liu, Chih Long; Jin, Michael C; Macaulay, Charles W; Neidert, Nicolas; Volk, Timo; Eisenblaetter, Michel; Rauer, Sebastian; Heiland, Dieter H; Finke, Jürgen; Duyster, Justus; Wehrle, Julius; Prinz, Marco; Illerhaus, Gerald; Reinacher, Peter C; Schorb, Elisabeth; Diehn, Maximilian; Alizadeh, Ash A; Scherer, Florian

Treatment Strategies and Prognostic Factors in Secondary Central Nervous System Lymphoma: A Multicenter Study of 124 Patients

继发性中枢神经系统淋巴瘤的治疗策略和预后因素:一项纳入124例患者的多中心研究

Treiber, Hannes; Nilius-Eliliwi, Verena; Seifert, Nicole; Vangala, Deepak; Wang, Meng; Seidel, Sabine; Mika, Thomas; Marschner, Dominik; Zeremski, Vanja; Wurm-Kuczera, Rebecca; Caillé, Leandra; Chapuy, Claudia I; Trümper, Lorenz; Fischer, Thomas; Altenbuchinger, Michael; Wulf, Gerald G; Illerhaus, Gerald; Dietrich, Sascha; Schroers, Roland; Chapuy, Björn

The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial

JAK1/2抑制剂鲁索替尼在COVID-19患者中诱发过度炎症反应:RuxCoFlam试验

Hammersen, J; Birndt, S; Döhner, K; Reuken, P; Stallmach, A; Sauerbrey, P; La Rosée, F; Pfirrmann, M; Fabisch, C; Weiss, M; Träger, K; Bremer, H; Russo, S; Illerhaus, G; Drömann, D; Schneider, S; La Rosée, P; Hochhaus, A

International multicenter retrospective analysis of thiotepa-based autologous stem cell transplantation for secondary central nervous system lymphoma

一项基于噻替哌的自体干细胞移植治疗继发性中枢神经系统淋巴瘤的国际多中心回顾性分析

Khwaja, Jahanzaib; Kirkwood, Amy A; Isbell, Lisa K; Steffanoni, Sara; Goradia, Harshita; Pospiech, Lisa; Fail, Thomas; Nicholson, Emma; Fletcher, Kate; Linton, Kim M; Parsons, Katrina E; Elmusharaf, Nagah; Eccersley, Lydia; Eyre, Toby A; Chaganti, Sridhar; Smith, Jeffrey; Thakrar, Nisha; Kutilina, Alexandra; Calimeri, Teresa; Martinez-Calle, Nicolas; El-Sharkawi, Dima; Osborne, Wendy; Illerhaus, Gerald; Fox, Christopher P; Ferreri, Andrés J M; Schorb, Elisabeth; Cwynarski, Kate

P725: BATTLE OF THE GIANTS – COMPARISON OF IPSS-M AND IPSS-R IN PATIENTS WITH MISSING MOLECULAR DATA EXCEPT TP53 MUTATION STATUS FROM THE DÜSSELDORF MDS REGISTRY

P725:巨人之战——杜塞尔多夫MDS登记处中除TP53突变状态外缺乏其他分子数据的患者IPSS-M和IPSS-R的比较

Bonig, Halvard; Verbeek, Mareike; Herhaus, Peter; Braitsch, Krischan; Beutel, Gernot; Schmid, Christoph; Müller, Nadine; Bug, Gesine; Döring, Michaela; von Stackelberg, Arend; Tischer, Johanna; Ayuk, Francis; Wulf, Gerald; Holtick, Udo; Pfeffermann, Lisa-Marie; Jahrsdörfer, Bernd; Schrezenmeier, Hubert; Kuci, Selim; Kuci, Zyrafete; Zens, Anke; Tribanek, Michael; Zeiser, Robert; Huenecke, Sabine; Bader, Peter; Birndt, Sebastian; Hammersen, Jakob; Döhner, Konstanze; Reuken, Philipp; Sauerbrey, Paul; Rosée, Felicitas La; Pfirrmann, Markus; Fabisch, Christian; Illerhaus, Gerald; Weiß, Manfred; Träger, Karl; Bremer, Hinrich; Drömann, Daniel; Schneider, Sylke; Rosee, Paul La; Hochhaus, Andreas; Schulz, Felicitas; Kellersmann, Carolin; Betz, Beate; Hildebrandt, Barbara; Ganster, Christina; Heiders, Johannes; Nusch, Arndt; Lipke, Jörg; Beier, Fabian; Sockel, Katja; Pfeilstoecker, Michael; Haase, Detlef; Götze, Katharina; Nachtkamp, Kathrin; Gattermann, Norbert; Germing, Ulrich